CN104338121A - Medical safe sterilization disinfectant - Google Patents
Medical safe sterilization disinfectant Download PDFInfo
- Publication number
- CN104338121A CN104338121A CN201310327915.9A CN201310327915A CN104338121A CN 104338121 A CN104338121 A CN 104338121A CN 201310327915 A CN201310327915 A CN 201310327915A CN 104338121 A CN104338121 A CN 104338121A
- Authority
- CN
- China
- Prior art keywords
- parts
- medical
- lactoferrin
- medical safe
- chlorhexidine gluconate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention relates to a medical safe sterilization disinfectant which comprises the following components: 1-2 parts of norfloxacin, 7-10 parts of nonylphenol polyoxyethylene ether, 2-5 parts of metronidazole, 3-8 parts of lactoferrin, 5-8 parts of chlorhexidine gluconate solution, 1-2 parts of lauroyl diethanolamide and 50-70 parts of water, wherein the chlorhexidine gluconate solution is preferably 7 parts, and the lactoferrin is preferably 5-7 parts. The medical safe sterilization disinfectant not only can be used as a daily medical disinfectant in a hospital to clean the skin before and after injection or minimally invasive surgery, but also can be produced in antiseptic prep pads, antiseptic cotton swabs and antiseptic wet wipes of different specifications, and fully ensures the sterility and the safety of the product; and the product can be used directly when be unpacked, so that the cross contamination and the cross infection of the intermediate link are avoided.
Description
Technical field
The present invention relates to a kind of disinfectant technical field, particularly relate to a kind of medical safe disinfection solution.
Background technology
At present, in medicinal therapeutic process, the alcohol series bactericidal agent for skin degerming is generally ethanol and isopropyl alcohol.Ethanol for disinfection to human non-toxic, but has stimulation to mucosa, so can not be used for the sterilization of mucosa; Frequent use ethanol disinfection hands and skin, can make xerosis cutis, coarse and breach; Partial rubber goods and plastic Long contact time ethanol can be hardening; A few peoples are irritated to ethanol, and occur after contact dermatitis, symptom of erythema occur, this kind of people should not use ethanol to carry out skin degerming.At present, the bactericidal effect of the disinfection sanitizer antibacterial that market uses is unstable, the more important thing is that this disinfection sanitizer has certain specific aim to Irrigation and sterilization, it has certain scope of application, all pathogenic bacterias can not be killed, in medical practice, need applicable specific area safety, stable, effective Medical antiseptic solution more and more urgently.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of medical safe disinfection solution.
For solving the problems of the technologies described above, medical safe disinfection solution of the present invention, it contains following component, norfloxacin 1-2 part, NPE 7-10 part, metronidazole 2-5 part, lactoferrin 3-8 part, chlorhexidine gluconate solution 5-8 part, lauric acid diethyl amide 1-2 part, water 50-70 part.
Described chlorhexidine gluconate solution is 7 parts.
Described lactoferrin is 5-7 part.
The present invention both can as the daily Medical antiseptic solution of hospital, for cleaning skin before and after injection or Minimally Invasive Surgery, also the disinfection pad of various different size can be produced into, the disinfecting liquid of disinfection swab stick and disinfection wet paper towel, fully ensure that aseptic and the safety of product, product can directly use after unpacking and filling, and avoids cross-contamination and the infection of intermediate link.
Detailed description of the invention
Embodiment 1
Medical safe disinfection solution of the present invention, it contains following component, norfloxacin 1 part, NPE 7 parts, metronidazole 5 parts, lactoferrin 8 parts, chlorhexidine gluconate solution 5 parts, lauric acid diethyl amide 1 part, 70 parts, water.
Embodiment 2
Medical safe disinfection solution of the present invention, it contains following component, norfloxacin 2 parts, NPE 7 parts, metronidazole 2 parts, lactoferrin 8 parts, chlorhexidine gluconate solution 5 parts, lauric acid diethyl amide 2 parts, 50 parts, water.
Embodiment 3
Medical safe disinfection solution of the present invention, it contains following component, norfloxacin 1 part, NPE 8 parts, metronidazole 3 parts, lactoferrin 5 parts, chlorhexidine gluconate solution 7 parts, lauric acid diethyl amide 1 part, 60 parts, water.
The above is only to preferred embodiment of the present invention, not does other forms of restriction to the present invention, and any those skilled in the art may utilize the technology contents of above-mentioned announcement to be changed or be modified as the Equivalent embodiments of equal change.Everyly do not depart from the present invention program's content, according to technical spirit of the present invention to any simple modification made for any of the above embodiments, equivalent variations and remodeling, all drop in protection scope of the present invention.
Claims (3)
1. a medical safe disinfection solution, is characterized in that: it contains following component, norfloxacin 1-2 part, NPE 7-10 part, metronidazole 2-5 part, lactoferrin 3-8 part, chlorhexidine gluconate solution 5-8 part, lauric acid diethyl amide 1-2 part, water 50-70 part.
2. according to medical safe disinfection solution according to claim 1, it is characterized in that: described chlorhexidine gluconate solution is 7 parts.
3. according to medical safe disinfection solution according to claim 2, it is characterized in that: described lactoferrin is 5-7 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310327915.9A CN104338121A (en) | 2013-07-31 | 2013-07-31 | Medical safe sterilization disinfectant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310327915.9A CN104338121A (en) | 2013-07-31 | 2013-07-31 | Medical safe sterilization disinfectant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104338121A true CN104338121A (en) | 2015-02-11 |
Family
ID=52495112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310327915.9A Pending CN104338121A (en) | 2013-07-31 | 2013-07-31 | Medical safe sterilization disinfectant |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104338121A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106580939A (en) * | 2016-12-15 | 2017-04-26 | 武汉冠信康医疗科技有限公司 | Chlorhexidine gluconate disinfectant |
| CN107568266A (en) * | 2017-09-15 | 2018-01-12 | 南通荣成医药化工有限公司 | A kind of Medical antiseptic solution |
-
2013
- 2013-07-31 CN CN201310327915.9A patent/CN104338121A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106580939A (en) * | 2016-12-15 | 2017-04-26 | 武汉冠信康医疗科技有限公司 | Chlorhexidine gluconate disinfectant |
| CN107568266A (en) * | 2017-09-15 | 2018-01-12 | 南通荣成医药化工有限公司 | A kind of Medical antiseptic solution |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1740166B1 (en) | Therapeutic antimicrobial compositions and methods | |
| BR112014008255B1 (en) | ANTIMICROBIAL COMPOSITIONS AND METHODS USING THE SAME | |
| Abdel-Sayed et al. | Implications of chlorhexidine use in burn units for wound healing | |
| Patwardhan et al. | Disinfection, sterilization and operation theater guidelines for dermatosurgical practitioners in India | |
| KR20170033925A (en) | Spray compositions having antiviral efficacy and antibacterial agent | |
| CN102871870A (en) | Medical hand sterilizer | |
| Graça et al. | Indirect consequences of coronavirus disease 2019: Skin lesions caused by the frequent hand sanitation and use of personal protective equipment and strategies for their prevention | |
| CN103202827A (en) | Chlorhexidine gluconate and isopropanol mixed disinfectant | |
| CN103860821A (en) | Broad-spectrum disinfectant composition | |
| CN104338121A (en) | Medical safe sterilization disinfectant | |
| CN101810639A (en) | Broad-spectrum touch-out medical bactericide and preparation method thereof | |
| Frees | Equine practice on wound management: wound cleansing and hygiene | |
| CN104523466A (en) | Chinese herbal medicinal skin mucosa disinfection wet wipe | |
| CN106075410A (en) | A kind of disposable Clean Living agent of pre-operative patients | |
| CN104188848B (en) | Cooperatively used combined bag for cleaning and disinfecting skin after dog and animal injuries | |
| CN102845489A (en) | Improved disinfectant | |
| JP2013508457A (en) | Apparatus, methods and compositions for controlling infection | |
| CN101816678A (en) | Broad-spectrum contact type hemostatic medical fungicide and preparation method thereof | |
| CN104435605A (en) | Preparation method of Chinese herbal medicine skin disinfectant | |
| CN104490936A (en) | Skin disinfectant | |
| CN104434667A (en) | Chinese herbal medicine skin disinfectant wet wipe | |
| CN105497572A (en) | Vagina-cleaning sanitary lotion | |
| CN103520217A (en) | Biological bactericide and application thereof | |
| CN101869537B (en) | Vagina-cleaning wet tissue for women | |
| CN202724444U (en) | Novel sterilization rod |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150211 |
|
| WD01 | Invention patent application deemed withdrawn after publication |